ALZN - CIK 0001677077
Alzamend Neuro, Inc. (ALZN) reported net income of -$4.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$4.51M | +54.6% |
| FY 2024 | -$9.95M | +33.1% |
| FY 2023 | -$14.88M | -20.4% |
| FY 2022 | -$12.36M | -145.0% |
| FY 2021 | -$5.05M | -14.4% |
| FY 2020 | -$4.41M | - |
Alzamend Neuro, Inc. (ALZN) reported net income of -$4.51M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Alzamend Neuro, Inc.'s net income declined from -$4.41M to -$4.51M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.